Esperion Therapeutics
ESPR
#7379
Rank
NZ$0.65 B
Marketcap
$3.31
Share price
-1.10%
Change (1 day)
-6.44%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: NZ$0.65 Billion

As of January 2025 Esperion Therapeutics has a market cap of NZ$0.65 Billion. This makes Esperion Therapeutics the world's 7379th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.65 B-18.14%
2024NZ$0.79 B48.15%
2023NZ$0.53 B-25.64%
2022NZ$0.72 B62.19%
2021NZ$0.44 B-52.26%
2020NZ$0.93 B-61.64%
2019NZ$2.43 B32.35%
2018NZ$1.83 B-24.26%
2017NZ$2.42 B495.78%
2016NZ$0.40 B-44.34%
2015NZ$0.73 B-30.25%
2014NZ$1.04 B309.35%
2013NZ$0.25 B

End of Day market cap according to different sources

On Jan 29th, 2025 the market cap of Esperion Therapeutics was reported to be:

NZ$0.65 Billion
by Nasdaq info icon info icon
NZ$0.65 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$6.96 B 968.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.54 B 3,204.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$267.79 B 40,967.84%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$132.39 B 20,203.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.14 B 689.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.53 B-18.33%๐Ÿ‡บ๐Ÿ‡ธ USA